Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
Editas Medicine Announces Pricing of Offering of Common Stock
12:00am, Wednesday, 24'th Jun 2020
CAMBRIDGE, Mass., June 23, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced the pricing...
Corporate interests on edge as progressive Democrats surge ahead of NY and Kentucky primaries
12:08pm, Tuesday, 23'rd Jun 2020
Three progressive Democrats are poised for big, establishment shaking wins in Tuesday's primary elections in New York and Kentucky, leading corporate interests and big money donors to pour millions in
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Gilead hopes to start inhaled remdesivir trial in healthy volunteers in August
02:32pm, Monday, 22'nd Jun 2020
In an open letter, Gilead CEO Daniel O'Day wrote that the company plans to start screening participants for the Phase I study program starting this week. The biotech company also plans to test intrave
Second deadliest Ebola outbreak ever is days from being declared over
08:50am, Monday, 22'nd Jun 2020
The outbreak that has ravaged a corner of the Democratic Republic of the Congo for nearly two years has been one of the most challenging to snuff out.
JPMorgan Chase & Co. Sells 519,579 Shares of Adverum Biotechnologies Inc (NASDAQ:ADVM)
04:44am, Monday, 22'nd Jun 2020
JPMorgan Chase & Co. cut its holdings in shares of Adverum Biotechnologies Inc (NASDAQ:ADVM) by 70.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities
Top Stocks To Buy As Existing Home Sales Data Shows Plummet In May
12:00am, Monday, 22'nd Jun 2020
Despite the low numbers shown in the Existing Home Sales data the went out today, June is expected to be an improvement with the economy reopened and people comfortable with seeing houses. All optimis
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 12-Month High at $646.33
02:22am, Sunday, 21'st Jun 2020
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)’s share price hit a new 52-week high during trading on Friday . The stock traded as high as $646.33 and last traded at $643.92, with a volume of 2035075 s
Editas Medicine Inc (NASDAQ:EDIT) Given Average Rating of “Hold” by Analysts
02:06am, Sunday, 21'st Jun 2020
Shares of Editas Medicine Inc (NASDAQ:EDIT) have been assigned a consensus rating of “Hold” from the ten brokerages that are presently covering the stock, MarketBeat.com reports. Six research anal
Adverum Biotechnologies Inc (NASDAQ:ADVM) Director Sells $218,600.00 in Stock
07:03am, Saturday, 20'th Jun 2020
Adverum Biotechnologies Inc (NASDAQ:ADVM) Director Mehdi Gasmi sold 10,000 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $21.86, fo
Editas Medicine (NASDAQ:EDIT) Trading Up 8.6%
05:50am, Saturday, 20'th Jun 2020
Editas Medicine Inc (NASDAQ:EDIT)’s share price rose 8.6% during mid-day trading on Thursday . The stock traded as high as $33.55 and last traded at $32.45, approximately 1,818,154 shares changed ha
Insider Selling: Adverum Biotechnologies Inc (NASDAQ:ADVM) President Sells $325,060.28 in Stock
05:40am, Saturday, 20'th Jun 2020
Adverum Biotechnologies Inc (NASDAQ:ADVM) President Leone D. Patterson sold 13,171 shares of the firm’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average p
